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COSMETIC LABELING: THE FDA's RESPONSE
TO CONSUMER NEEDS
Ronald G. Fischer*
INTRODUCTION
For a long time consumers have been concerned about the
ingredients in the cosmetics they buy. With the expanding use of
cosmetics by both men and women, there has emerged a com-
pelling need for information which will enable consumers to
compare and evaluate the countless cosmetic products on the
American market and to protect themselves from deleterious ef-
fects of certain cosmetic ingredients. Consumers, of course, want
to know which brand or type of cosmetic within their price range
will best satisfy their needs. But more importantly, each individ-
ual consumer must also know what substances are in each cos-
metic in order to avoid those ingredients to which he may have an
allergic reaction. In response to these needs there has been con-
siderable emphasis by consumer groups in recent years on re-
quiring ingredient labeling of cosmetics.
The Federal Food, Drug and Cosmetic Act of 1938
(FDCA) includes cosmetics within its coverage' but nowhere re-
quires ingredient labeling of cosmetic products. Some congres-
sional interest in amending the Food, Drug and Cosmetic Act has
emerged at various times, but no bills have moved beyond the
committee stage. An industry group, the Cosmetic, Toiletry,
and Fragrance Association,2 has helped to implement voluntdry
ingredient disclosure but these disclosures are made only to the
Food and Drug Administration (FDA), the regulatory authority
* B.A., University of Missouri, 1955; Director, Compliance Branch, San
Francisco District, Food and Drug Administration. The Compliance Branch
deals with regulatory and advisory activities as well as consumer education and
informational services. This article represents the views of a member of the staff
of the Food and Drug Administration and does not express the Administration's
official policy.
1. 21 U.S.C. §§ 361-63 (1970) [hereinafter cited as FDCA].
2. The Cosmetic, Toiletry, and Fragrance Association is a trade organiza-
tion with a membership including approximately two-hundred companies which
produce more than eighty-five per cent of the United States' total production.
See 36 Fed. Reg. 16934 (1971).
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charged with the responsibility for enforcement of the FDCA, and
not to the general public.'
Since the FDCA itself requires no ingredient labeling of cos-
metics, the Food and Drug Administration has utilized the
Fair Packaging and Labeling Act4 as the enabling legislation to
promulgate a regulation mandating ingredient labeling on cos-
metics after March 31, 1975. This article will outline these two
acts which bear on cosmetic labeling. It will trace the legislative
failure to respond to consumer demands for better cosmetic in-
formation and the FDA's subsequent use of voluntary ingredi-
ent labeling regulations promulgated under the Food, Drug and
Cosmetic Act and later mandatory labeling through regulations
promulgated under the Fair Packaging and Labeling Act. It is
only with these very recent FDA regulations that consumers have
won meaningful and useful disclosure of cosmetic ingredients.
THE FOOD, DRUG AND COSMETIC ACT
Enacted in 1938, the Federal Food, Drug and Cosmetic Act5
constitutes the basic consumer law in the area of cosmetic regula-
tion. The term cosmetic is broadly defined to include any arti-
cle which is applied to the human body or any part thereof by
means of rubbing, pouring, sprinkling or spraying, with the intent
to cleanse, beautify, promote attractiveness or otherwise alter
the appearance of part or all of the body.' The FDCA definition
also includes any component article of a cosmetic, but specifically
excludes soap from the definition.7
A central concern of the Act is to avoid dangerous adulter-
ation and misbranding of cosmetics. Under the Act, a cosmetic
3. Regulations regarding voluntary ingredient disclosures provide that such
information may be passed on to the public on request except that any informa-
tion "constituting a trade secret or other privileged and confidential commercial
information exempt from disclosure to the public" must be designated confiden-
tial by the party submitting it and must be accompanied by a specification of
the grounds justifiying its confidentiality. The FDA may then determine
whether the information is indeed confidential or not. 21 C.F.R. § 172.9
(1973). Under FDA proposed rules on Public Information (37 Fed. Reg. 9132-
33 (1972)), the asserted confidentiality of voluntarily submitted material will be
determined at the time of submission, and if the information is found not to qual-
ify as confidential the party submitting it will have an opportunity to withdraw
it to avoid public disclosure.
4. 15 U.S.C. § 1451 et seq. (1970) [hereinafter cited as FPLA].
5. 21 U.S.C. § 301 etseq. (1970).
6. id. § 321(i)(1), (2). Categories of cosmetic products are: baby prod-
ucts, bath preparations, eye make-up preparations, fragrance preparations, hair
preparations, hair coloring preparations, make-up preparations, manicuring prep-
arations, oral hygiene products, personal cleanliness, shaving preparations, skin
care preparations, and suntan and sunscreen preparations. 21 C.F.R. § 172.5 (c)
(1973).
7. 21 U.S.C. § 321(i)(2) (1970).
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is considered adulterated if it contains a poisonous or deleterious
substance,8 or if it has been contaminated in preparation or pack-
aging.9
Misbranding of cosmetics may occur in any of the following
circumstances: 1) the labeling is false or misleading in any par-
ticular; 2) the label does not bear the name and business address
of either the manufacturer, packer or distributor; 3) the label does
not present an accurate statement of the quantity of the contents by
weight, measure or numerical count; 4) the required explana-
tion of quantity of contents and name of manufacturer is not con-
spicuously printed; 5) the container is itself misleading; 6) the
product is a color additive and the labeling does not conform with
the packaging and labeling requirements applicable to color addi-
tives; or, 7) the packaging and labeling violates any of the regula-
tions issued pursuant to the Poison Prevention Packaging Act of
1970.10
Despite its obvious relevance to avoiding adulteration and
misbranding, ingredient labeling is not required by the FDCA.11
This absence of a labeling provision may be contrasted with the
FDCA's requirement that the labeling on the container of any
food product (except those with standard recipes) must disclose in
clear terminology the ingredients used. 2 In addition to the infor-
mation required on cosmetics labels, food labels must bear the
common and usual name of the food product and, if two or more
ingredients are combined, the common name of each. If any of
the additional ingredients are spices, flavors or colorings, these
may be designated as such without further specification."'
With regard to drugs,' 4 the third commodity group regulated
by the Food, Drug and Cosmetic Act, the Act requires that the
established name and quantity of each active ingredient in drugs
8. Cosmetics are among the items controlled by the Poison Prevention
Packaging Act of 1970, 15 U.S.C. § 1471 et seq. (1970).
9. 21 U.S.C. § 361 (1970) ("poisonous", "deleterious" and "contaminated"
are not defined by the FDCA).
10. Id. § 362; see also Poison Prevention Packaging Act of 1970, 15 U.S.C.
§ 1471 et seq. (1970).
11. 21 U.S.C. § 362 (1970).
12. Id. § 343.
13. Id.
14. Id. § 321(g)(1) defines "drug" as:
(a) Articles recognized in the official United States Pharmacopoeia, of-
ficial Homoeopathic Pharmacopoeia of the United States, or official
National Formulary, or any supplement to any of them; and (B) arti-
cles intended for use in the diagnosis, cure, mitigation, treatment, or
prevention of disease in men or other animals; and (C) articles (other
than food) intended to affect the structure or any function of the body
of men or other animals; and (D) articles intended for use as a com-
ponent of any article specified in clauses (A), (B), or (C) of this para-
graph; but does not include devices or their components, parts, or ac-
cessories.
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fabricated from two or more ingredients be disclosed on the la-
bel. Furthermore, the label must state the quantity, kind and
proportion of alcohol or any of eighteen other named ingredients,
whether active or inactive.15
Thus, of the three basic commodity groups regulated by
the Food, Drug and Cosmetic Act only cosmetic labels need not
include a list of ingredients. A review of the FDCA's legisla-
tive history reveals no responsiveness on the part of the Congress
to efforts to include an ingredient labeling requirement for the
cosmetics industry similar to those imposed upon the food and
drug industry.
Efforts to Include Cosmetic Ingredient Labeling Requirements
Within the FDCA
In 1933, the first 'bill to revise the existing Federal Food and
Drug Act of 1906 was introduced into the Senate. Even at this
early date efforts were being made to require that private for-
mula drugs, that is, those which were not included in a recognized
industry listing of drugs and drug formulae, bear the name,
quantity and proportion of each medicinal or phsyiologically
active ingredient on their labels. 1 6  This revision might have had
an impact on cosmetic labeling if private formula drugs had been
broadly defined to include many cosmetics.' 7 At best the bill
could have been read to imply that a particular cosmetic, if likely
to be used medicinally, could satisfy the definition of "drug"
and therefore be required to bear a list of active ingredients on
the label.1 Because of that possible implication the bill was vig-
orously opposed by the cosmetic industry.'9 Industry representa-
tives expressed the fear that the proposed bill would be inter-
preted to require the revelation of cosmetic formulae which would
allow imitators to flood the cosmetic market with inferior prod-
ucts sold at lower prices and cause "serious losses" to the estab-
15. Id. § 352(e).
16. C. DUNN, FEDERAL FOOD, DRUG AND COSMETIC ACT: A STATEMENT OF
ITS LEGISLATIVE RECORD 41 (1938) [hereinafter cited as DuNN].
17. Id. at 37.
18. Id. For the definition of a "drug" in the FDCA, see 21 U.S.C. § 321
(g)(1) (1970) supra note 14.
19. Counsel for the Associated Manufacturers of Toilet Articles testified that
according to his interpretation of the bill, a hypothetical shaving lotion which
bore on its label the statement "good for bleeding" therefore became at once a
drug as well as a cosmetic and subject to disclosure requirements. In his opin-
ion, the result could be a label replete with twenty or more chemical designa-
tions, essential oils, synthetic drugs, alcohol, fixatives, and other items which fur-
nished no useful information to the consumer and disclosed valuable trade secrets
to competitors. Hearings on S. 1944 Before a Subcomm. of the Senate Comm.
on Commerce, 73rd Cong., 2nd Sess. 293 (1933).
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lished cosmetic industry." They urged that a provision be added
to explicitly bar any formulae disclosure requirement.2 The bill
died in committee.22
Two successor bills in 193423 suffered the same fate; neither
included any provision for the ingredient labeling of cosmetics.
However, testimony at Congressional hearings increasingly favored
such a revision of the 1906 Act. For example, during hearings
held before the Committee on Commerce, a physician specializing
in allergic medicine estimated that about fifteen percent of the
white population of the United States was allergic to one or more
substances. He noted that on frequent occasions he had observed
allergic reactions to cosmetics, primarily as a result of one partic-
ular ingredient, orris -root.24 The physician urged mandatory list-
ing of the basic ingredients of cosmetics on their labels. 25
Still another bill to revise the Food and Drug Act, again
without ingredient labeling requirements, was introduced in
1935.26 Once again the need for disclosure of cosmetic ingredi-
ents was urged at hearings, this time by speakers representing
various public interest organizations and such groups as the
American Dietetic Association and the American Home Econom-
ics Association.27 The most compelling justification urged upon
the Committee for labeling requirements was -the need 'to provide
information to the allergic consumer which would enable him or
her to avoid harmful substances. Support for this position was
voiced by both a consulting chemist and an allergy sufferer, each
of whom testified as to the desirability of requiring full disclosure
of cosmetic ingredients. 28  The general consensus among those
testifying before the Committee was -that the proposed law,
which did not include a labeling requirement, was necessary and
laudable but did not go far enough.
On May 28, 1935, following debate and amendment, the bill
was unanimously passed by the Senate and sent to the House of
Representatives.29  After three years of debate and delay the bill
20. Id. at 297-98.
21. Id. at 398.
22. DUNN, supra note 5 at 50.
23. id. at 51 and 68.
24. Orris root is used in cosmetic preparations for two reasons: 1) its fleshy
hue and mild fragrance; 2) its marked ability to retain its scent for a consider-
able period of time.
25. Hearing on S. 2800 Before the Senate Comm. on Commerce, 73rd Cong.,
2nd Sess. 494 (1934).
26. S.5, 74th Cong., 1st Sess., 79 Cong. Rec. 100 (1935).
27. Hearings on S. 5 Before a Subcomm. of the Senate Comm. on Com-
merce, 74th Cong., 1st Sess. 34-5 (1935).
28. Id. at 218 and 304-10.
29. 79 Cong. Rec. at 8356 and 8400 (1935).
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was finally passed by the House and signed into law by President
Franklin D. Roosevelt on June 25, 1938,30 as the Food, Drug
and Cosmetic Act of 1938. Although the new law was far from
perfect, it was a step forward in that it subjected cosmetics gener-
ally to federal regulatory control for the first time.
Voluntary Registration and Filing of Cosmetic Ingredients
Although attempts to include ingredient labeling require-
ments in the FDCA failed, the extensive hearing testimony in fa-
vor of ingredient labeling found in the Act's legislative history
along with the Food and Drug Administration's increased recep-
tiveness to meeting consumer needs finally spurred, in 1971, the
giant cosmetic industry31 to fashion its own voluntary ingredient
disclosure regulations.32 At the same time, consumer groups
have continued to push for further mandatory ingredient disclosure
provisions.
The Cosmetic, Toiletry, and Fragrance Association filed
two petitions33 with the FDA in August, 197 1,3 suggesting reg-
ulations providing for voluntary registration by producers of cos-
metic products and voluntary filing of cosmetic ingredient lists.
The Association's expressed rationale for these petitions was that
availability to the FDA of the names and addresses of establish-
ments producing cosmetic products as well as information on in-
gredients used in cosmetics would lead to more efficient enforce-
ment of the FDCA and would therefore serve the public interest.
The disclosure provided for was limited, however, by a section
aimed at insuring confidentiality of ingredient filings by provid-
ing that these statements or any compilation of them constituted
trade secrets or confidential information3 5 and were exempt from
public disclosure under both the Administrative Procedure Act
(Freedom of Information Act) 6 and the FDCA.7 Under the
30. DUNN, supra note 5 at 1015.
31. Whalley, U.S. Sales of Cosmetics and Toilet Preparations, SOAP, PER-
FUMERY & COSMETIC J., Apr. 1973, at 217-18. Conservative estimates place the
annual gross income for the cosmetic industry during 1972 at four billion dol-
lars.
32. The cosmetic industry later made a similar proposal for voluntary filing
with the FDA of "cosmetic product experiences," that is, adverse reactions to cos-
metics. 38 Fed. Reg. 28914-17 (1973).
33. Regulations proposed by the public are submitted for FDA consideration
by means of petitions. The proposal, as defined in and limited by the petition,
is then subject to public comment and hearings before the FDA to determine
whether to adopt it, reject it or adopt it with modifications.
34. 36 Fed. Reg. 16934-37 (1971).
35. Id. at 16936.
36. 5 U.S.C. § 552(b)(4) (1970).
37. 21 U.S.C. § 331(j) (1970).
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Association proposal, such information could be disclosed only
in the course of testimony by an FDA employee in a court action
brought by the FDA for enforcement of the Food, Drug and
Cosmetic Act provisions.88 Even then, disclosure could only be
made in camera and only when the information was relevant to
the violation charged. 9  The petitions further requested that if
confidentiality of the statements could not be honored, the infor-
mation provided to the FDA would be destroyed or returned to the
submitting party. 40
The proposal on voluntary listing of ingredients did not in-
clude a requirement for exact quantitive information. The in-
gredients were to be listed in descending order of a predominance
by weight (with the exception that fragrances and flavors could be
designated as such without naming the component ingredients);41
the amount of each ingredient could be designated by one of
seven quantitive ranges from over fifty percent to less than 0.1
percent.42  Under this proposal ingredient information is to be
filed with the FDA rather than published on cosmetic product la-
bels.48
Between August 26, 1971, and September 25, 1971, the pro-
posed regulations were open to public comment and twenty-two
comments were received by the FDA Commissioner. In one of
these comments a member of Congress urged mandatory rather
than voluntary registration and filing of ingredient statements by
cosmetic producers.4 4 Other comments challenged -the legality of
voluntary regulations under the FDCA 45 and argued that author-
ity now existed to require mandatory registration of cosmetic
producers, filing of cosmetic statements, and labeling of ingredi-
ents on cosmetic products.
In reviewing these comments the Commissioner determined
that he had the authority to accept both the voluntary registration
and voluntary filing of cosmetic product ingredient statements.46
He asserted that a regulation making such statements mandatory
could result in lengthy litigation which would serve to seriously deter
'the FDA from obtaining the type of information expected from vol-
untary filings.47 While the Commissioner recognized that the recom-
mendation for ingredient labeling on cosmetics was meritorious and
38. 36 Fed. Reg. 16936 (1971).
39. Id.
40. Id. at 16936-37.
41. Id. at 16936.
42. Id.
43. id. at 16935.
44. 37 Fed. Reg. 7151 (1972). The member of Congress was not named.
45. 21 U.S.C. § 301 et seq. (1970).
46. 37 Fed. Reg. 7151 (1972).
47. Id.
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would help prevent deception of consumers and facilitate value
comparisons, he concluded that this issue was not explicitly raised
by the Cosmetic, Toiletry and Fragrance Association petition;41
therefore, no regulation requiring ingredient labeling could be
promulgated on the basis of that petition. He did note, however,
that the possibility of publishing a proposal under the Fair Pack-
aging and Labeling Act for labeling of sensitizing ingredients was
presently under consideration.49
In response to objections raised by a public interest group to
the all-inclusive scope of the confidentiality provisions in the pro-
posed voluntary disclosure regulation,5" -the Commissioner modi-
fied the proposal to make the confidentiality section conform to
the Administ-rative Procedures Act.5 Accordingly, under the reg-
ulation as amended any information alleged to be a trade secret
must be clearly marked as confidential by the submitting party
and must be accompanied by a statement setting forth adequate
grounds to justify its confidentiality.52  Furthermore, if the FDA
concludes that an item so marked is not confidential material"
and therefore not exempt from disclosure to the public, the person
submitting the information must be informed and given an op-
portunity to appeal that decision to the Food and Drug Admin-
istration Assistant Commissioner for Public Affairs. 54
In April of 1972, the revised regulations concerning volun-
tary filing of ingredients55 were published by the Commissioner.
The following August, forms were available for voluntary filing of
cosmetic ingredients and cosmetic raw material composition
statements, and an effective date thirty days 'from issuance of the
directive was established for -the new regulation. 56  As of October,
1973, 754 manufacturing establishments and 7,200 formulae rep-
resenting eighty percent of the cosmetic products sold in this
country had been registered with the FDA.57
48. Id.
49. Id. at 7152. See notes 58-63 and accompanying text infra for a discus-
sion of regulations under the FPLA.
50. Id.
51. Id. The Administrative Procedures Act, 5 U.S.C. § 552(b)(4) (1970),
provides that government agencies need not disclose information classified as a
"trade secret" to the public.
52. 21 C.F.R. § 172.9 (1973).
53. That is, not "trade secrets . . . obtained from a person and privileged
or confidential." 5 U.S.C. § 552(b)(4) (1970).
54. 21 C.F.R. § 172.9 (1973). The Assistant Commissioner for Public Af-
fairs makes the final decision as to confidentiality of the information.
55. 21 C.F.R. § 170 et seq. (1970).
56. 37 Fed. Reg. 17470 (1972). The forms are FD Form 2512 ("Cosmetic
Product Ingredient Statement") and FD Form 2513 ("Cosmetic Raw Material
Composition Statement").
57. HEW News, No. 73-46 (October, 1973).
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THE FAIR PACKAGING AND LABELING ACT
The FDA's issuance of voluntary cosmetic ingredient labeling
regulations in April of 1972, satisfied neither consumer groups
nor the FDA itself. The FDA turned to the Fair Packaging and La-
beling Act for authority to promulgate mandatory ingredient
labeling requirements.
The Fair Packaging and Labeling Act (FPLA),68 popularly
known as the "Truth in Packaging" act, was first introduced in
the Senate in 1965, and was signed into law on Nevember 3,
1966. The congressional purpose in enacting this legislation was
to enable consumers to make value comparisons of similar prod-
ucts sold under different brand names. The lawmakers believed
value comparisons would be made possible by requiring the
manufacturer to include on the product labels accurate quantity
information."0 Apparently the need for ingredient information
necessary to make quality comparisons among cosmetics was not
considered. The law deals with the packaging and labeling of
retail consumer commodities, ° which include cosmetics, 6' but
only quantity labeling rather than ingredient labeling is required.
The FDA is charged with regulation of food, over the counter
drugs, certain medical devices, and cosmetics, all of which are
also subject to the Fair Packaging and Labeling Act require-
ments. A significant section of the FPLA provides that the
agency given authority to promulgate regulations over commodi-
ties covered by the FPLA may issue additional regulations under
the authority of the FPLA which are necessary to prevent the
deception of consumers or to facilitate value comparisons of any
consumer commodity.62 Under the Act ,the Secretary of Health, Ed-
ucation and Welfare, and through him the FDA, assumes this au-
thority to promulgate additional regulations of food, drugs and cos-
metics.63 Under this authority the FDA considered issuing a regula-
tion requiring mandatory labeling of sensitizing cosmetic ingre-
dients.64
58. 15 U.S.C. § 1451 etseq. (1970).
59. Id. § 1451.
60. Id. § 1452(a).
61. Retail consumer commodities are defined as:
Any food, drug, device or cosmetic (as those terms are defined in the
Federal Food, Drug and Cosmetic Act), and any other article, product
or commodity of any kind or class which is customarily produced or
distributed for sale through retail sales agencies or instrumentalities for
consumption by individuals, or use by individuals for purposes of per-
sonal care or in the performance of services ordinarily rendered within
the household, and which usually is consumed or expended in the
course of such consumption or use.
Id. § 1459(a).
62. Id. § 1454(c).
63. Id. § 1454(a).
64. 37 Fed. Reg. 7151 (1972).
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Mandatory Cosmetic Ingredient Labeling Requirements
While the FDA-proposed regulation was under consideration
a consumer petition65 was submitted to the FDA calling for reg-
ulation of cosmetic ingredient labeling. 6  In the statement of
grounds for such regulation, the petitioners referred to the fact
that the FDA was considering a proposal under the FPLA for
the labeling of sensitizing ingredients.6 7  The petitioners agreed
that this would contribute toward protecting those Americans
who suffer from allergic reactions; however, they did not be-
lieve such labeling would fully inform consumers and enable them
to make value comparisons. They contended that full ingredient
labeling would promote fair and efficient functioning of a free
market economy by allowing consumers to "vote with their pocket-
books" and increase the competitive posture of the marketplace.
Labeling is also important to the consumer as a health measure
and any cosmetic product which is injurious has no value whatso-
ever and may in fact impose a significant risk on the buyer.
"There is no benefit-risk ratio with respect to cosmetics."6 8 Their
petition, like the FDA proposal, relied on the disclosure of proce-
dures established under the FPLA' 9 -to protect both the interest
of consumers in knowing the ingredients of a cosmetic preparation
and manufacturers' interest in protecting trade secrets.7 0
The consumer and FDA proposals were substantially simi-
lar.7  Both proposals included provision for labeling of ingredi-
ents in decreasing order of predominance on a principal dis-
play panel. However, the consumer proposal dealt more directly
with trade secret exceptions and the handling of trade secret in-
formation in emergency situations, 72 while the FDA proposal ap-
parently concentrated on remedying the problems created by
technical and ambiguous terms that could be placed on the la-
bel.73
65. 38 Fed. Reg. 3523-24 (1973). On May 17, 1972, a petition was sub-
mitted by Professor Joseph A. Page of Georgetown University, Anthony L.
Young, a student at the University, and the Consumer Federation of America.
66. Id. at 3524.
67. Id.
68. 38 Fed. Reg. 3523-24 (1973).
69. 15 U.S.C. § 1454(c)(3) (1970).
70. 38 Fed. Reg. 3524 (1973).
71. See 21 C.F.R. § 172.1 et seq. (1970).
72. 38 Fed. Reg. 3524 (1973). Under this proposal such information could
be made available on request to poison control centers and to licensed physi-
cians when necessary to assist in determining the cause of an adverse patient
reaction. Alternatively, any packager of cosmetics could supply the FDA with
information on diagnostic or remedial procedures adequate to permit evaluation
and treatment in emergency situations.
73. 21 C.F.R. § 172.5-172.6 (1973). The specific provisions for ingredient
designation are sections 172.6(c)-(d).
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Two-hundred and ninety-one comments were received in
response to the two proposals. These came from consumers, the
cosmetic industry, a government agency, trade and professional
associations and the like. An overwhelming majority of the
comments (273) endorsed cosmetic ingredient labeling.74 Sev-
eral comments questioned the legal basis for the proposals, con-
tending that the FPLA granted authority to establish ingredient
labeling only on a commodity-by-commodity basis and only as
necessary to prevent consumer deception or to facilitate value
comparison. The Commissioner concluded that for the pur-
poses of ingredient labeling, all cosmetics are appropriately con-
sidered a single "commodity" and that ingredient labeling is
necessary to prevent deception and facilitate value comparisons.tm
Relying upon the United States Supreme Court's decision in Wein-
berger v. Hynson, Westcott & Dunning,76 the Commissioner de-
cided that the most effective means of instituting the labeling re-
quirement would be to issue a comprehensive order governing
the entire spectrum of cosmetic products.
77
Many of the comments received by the FDA related to the
trade secret portion of the proposals, the meaning of cosmetic in-
gredient names, and the method of declaring flavor, fragrance
and color.78  In response, the Commissioner admitted that since
the FPLA does provide for protection of trade secrets, the regu-
lation must make provision for them.79  Further, the Commis-
74. 38 Fed. Reg. 289.2 (1973). Of those comments endorsing cosmetic in-
gredient labeling, eight specifically favored the consumer proposal (38 Fed. Reg.
3523-24 (1973)), and thirteen specifically endorsed the Commission proposal
(21 C.F.R. § 172.1 et seq. (1973)), ten were in opposition to both proposals, and
eight expressed neither endorsement nor opposition, but requested modification or
clarification.
75. 38 Fed. Reg. 38912 (1973).
76. 412 U.S. 609 (1973). In Weinberger, the Court held inter alia that the
FDA's administrative procedure of bringing together all manufacturers of a given
drug for a single hearing on proposed removal of the drug from the market for
safety or efficacy reasons did not deny individual manufacturers procedural due
process. Id. at 625.
77. 38 Fed. Reg. 28912 (1973). See note 6 supra for categories of cosmetic
products.
78. Id.
79. Id. The confidentiality provisions are found in 21 C.F.R. § 172.9 (1973)
which provides:
(a) Each item of information contained in, attached to, or in-
cluded with FD Forms 2512, 2513, 2514, and amendments thereto and
constituting a trade secret or other privileged and confidential commer-
cial information exempt from disclosure to the public must be clearly
marked as confidential. Each item of information so marked must be
accompanied by a statement setting forth adequate grounds to justify
its confidentiality. If the Food and Drug Administration concludes that
an item so marked is not exempt from disclosure to the public, the per-
son submitting the information will be informed and will be given an
opportunity to appeal that decision to the Assistant Commissioner for
Public Affairs, whose decision on the matter will be final.
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sioner recognized possible problems of definition and declared
that a new compendium or dictionary compiled by the Cosmetic,
Toiletry and Fragrance Association would be the controlling au-
thority on ingredient terms. 80 In regard to color and fragrance,
the Commissioner concluded that some provision should be made
for listing colors by name, even if the number of fragrances
and flavors would make their listing impractical.
The Regulation
The final regulation relating to cosmetic ingredient labeling
was published in the Federal Register in October, 1973.81 All cos-
metic labels ordered after March 31, 1974, and all cosmetic prod-
ucts labeled after March 31, 1975, are to comply with the regula-
tion which requires that ingredients be listed prominently and
conspicuously on any appropriate information panel in decreasing
order of predominance (except for fragrances and flavors) and
that all ingredients be listed by standardized names."' If a
package is too small, a tag or card with the required ingredient in-
formation must be securely attached to the container.88
Two details should be noted. Since this regulation is based
on the FPLA, it applies only to those products actually labeled
after the effective date of March 31, 1975. Products already
labeled and in inventory and products in distribution channels will
not be affected. However, many companies have already com-
plied with the labeling requirements and at least by the end of
1975 all cosmetics 'bearing labels without the new disclosures will
have been phased out. Secondly, sanctions which are provided
for the FDA include only civil actions: a civil seizure of goods
on the market or a request for an injunction. Criminal prosecu-
tion of offenders is not permitted under the FPLA. However,
the civil remedy should be sufficient to insure enforcement be-
(b) Data and information otherwise exempt from public disclosure
may be revealed in administrative or court enforcement proceedings
where the data or information are relevant. Any such use will be in
a manner that reduces public disclosure to the minimum necessary under
the circumstances.
(c) Data and information otherwise exempt from public disclosure
may be disclosed to consultants, advisory committees, and other persons
who are special government employees. Such persons are thereafter
subject to the same restrictions with respect to disclosure as any Food
and Drug Administration employee.
80. 38 Fed. Reg. 28912. The compendium is known as the CTFA Cosmetic
Ingredient Dictionary. If the CTFA Dictionary did not contain an appropriate
listing, the Commissioner determined that other compendia enumerated in the
regulations would control the designation. See 21 C.F.R. § 172.5(d)(2) (1973).
81. 38 Fed. Reg. 28913-14 (1973).
82. Id.
83. Id.
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cause of the potency of injunctive action. If there is a violation
of the injunction the accompanying contempt proceedings would
allow for as complete court supervision as there would be in a
criminal prosecution.
CONCLUSION
In -the last two and one-half years since the first proposal
by the cosmetic industry for voluntary filing of ingredients of cos-
metic products, substantial advances have been made in the regula-
tion of cosmetics. In 1975, when the regulation requiring full
ingredient labeling becomes effective, the hazard to consumers
from reactions to unknown ingredients in cosmetics will be greatly
diminished. In addition, consumers will be able to compare cosmet-
ic products to determine for themselves whether the product costing
five dollars is really worth ten times more than the product cost-
ing fifty cents.
From the inception of the Food, Drug and Cosmetic Act in
1938, few changes in the regulation of cosmetic labeling have
been won by consumers. It is only now, in a period of height-
ened consumer consciousness and increasing realization by both
the government and industry of the need to respond to consumer
that ingredient information has finally reached the cosmetic label.
[Voli, 14
